Eton Pharmaceuticals, Inc. (ETON)
64.43
+0.96
(+1.51%)
USD |
NASDAQ |
Aug 24, 16:00
64.97
+0.54
(+0.84%)
After-Hours: 20:00
Eton Pharmaceuticals Price : 64.43 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 63.90 | 66.37 | 62.90 | 64.43 | 801541.0 |
| Aug 21, 2026 | 59.76 | 64.00 | 59.76 | 63.47 | 640789.0 |
| Aug 20, 2026 | 60.99 | 62.58 | 59.59 | 59.91 | 586529.0 |
| Aug 19, 2026 | 63.55 | 63.83 | 60.06 | 61.48 | 608921.0 |
| Aug 18, 2026 | 61.10 | 63.56 | 60.00 | 63.43 | 872479.0 |
| Aug 17, 2026 | 59.15 | 62.87 | 56.65 | 61.73 | 1.285M |
| Aug 14, 2026 | 54.93 | 59.79 | 53.01 | 58.86 | 2.318M |
| Aug 13, 2026 | 42.11 | 43.19 | 40.66 | 40.80 | 696938.0 |
| Aug 12, 2026 | 41.99 | 43.18 | 41.18 | 41.58 | 463093.0 |
| Aug 11, 2026 | 43.60 | 43.60 | 40.61 | 42.05 | 584578.0 |
| Aug 10, 2026 | 44.50 | 45.35 | 43.12 | 43.67 | 370019.0 |
| Aug 07, 2026 | 46.09 | 46.60 | 44.55 | 44.60 | 277988.0 |
| Aug 06, 2026 | 47.36 | 47.36 | 44.40 | 46.18 | 532180.0 |
| Aug 05, 2026 | 47.97 | 48.39 | 45.45 | 45.97 | 389006.0 |
| Aug 04, 2026 | 45.09 | 46.11 | 44.99 | 45.83 | 341833.0 |
| Aug 03, 2026 | 46.52 | 46.55 | 43.49 | 45.14 | 470659.0 |
| Jul 31, 2026 | 49.09 | 49.09 | 46.01 | 46.42 | 484790.0 |
| Jul 30, 2026 | 47.08 | 49.20 | 46.75 | 49.03 | 604341.0 |
| Jul 29, 2026 | 46.57 | 50.18 | 46.55 | 48.13 | 699058.0 |
| Jul 28, 2026 | 43.58 | 47.16 | 42.92 | 46.66 | 891270.0 |
| Jul 27, 2026 | 42.73 | 43.84 | 42.06 | 42.31 | 365383.0 |
| Jul 24, 2026 | 44.14 | 44.55 | 42.39 | 42.59 | 385773.0 |
| Jul 23, 2026 | 43.29 | 44.91 | 42.90 | 44.14 | 571332.0 |
| Jul 22, 2026 | 43.32 | 43.93 | 42.70 | 43.58 | 584477.0 |
| Jul 21, 2026 | 41.33 | 43.76 | 40.86 | 43.20 | 652610.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Nektar Therapeutics | 73.69 |
| Pfizer Inc. | 27.97 |
| Elite Pharmaceuticals, Inc. | 0.2891 |
| Daré Bioscience, Inc. | 0.8015 |
| Liquidia Corp. | 70.27 |
Price Related Metrics
| PE Ratio | 170.31 |
| PS Ratio | 18.68 |
| Price to Book Value | 39.13 |
| Earnings Yield | 0.59% |
| Market Cap | 1.823B |
| Operating PE Ratio | 119.51 |
| Normalized PE Ratio | 168.09 |